Search clinical trials for: DS-8201a
Total 270 results
-
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo CompanyAstraZenecaCompletedNeoplasm, Breast | Adenocarcinoma, GastricTaiwan
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedMalignant Neoplasm of BreastJapan
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedAdvanced Solid TumorsUnited States, Japan
-
Daiichi SankyoRecruitingAdvanced Solid TumorJapan, United States
-
National Cancer Center Hospital EastDaiichi Sankyo Co., Ltd.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedNeoplasm, GastrointestinalKorea, Republic of, Japan
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedColorectal NeoplasmUnited States, Spain, Japan, Italy, United Kingdom
-
Daiichi SankyoAstraZenecaActive, not recruitingAdvanced Colorectal CancerKorea, Republic of, United States, Taiwan, Belgium, Spain, Japan, United Kingdom, France, Italy, Australia
-
National Cancer Institute (NCI)SuspendedOsteosarcoma | Recurrent OsteosarcomaUnited States
-
UNICANCERDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyActive, not recruiting
-
Daiichi Sankyo, Inc.AstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, France, Japan, United Kingdom, Canada
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
Daiichi SankyoAstraZenecaCompletedAdenocarcinoma Gastric Stage IV With Metastases | Adenocarcinoma - GEJUnited States, Spain, Belgium, Italy, United Kingdom
-
MedSIRDaiichi Sankyo, Inc.CompletedAdvanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal MetastasisSpain, Portugal
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingAdvanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)China
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
AstraZenecaDaiichi SankyoActive, not recruitingHER2-mutant Non-Small Cell Lung CancerChina
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.CompletedNon-Small Cell Lung CancerUnited States, Spain, Japan, Netherlands, France
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerChina, United States, Spain, Hungary, Israel, Korea, Republic of, Taiwan, Belgium, Austria, Russian Federation, Switzerland, Portugal, France, Canada, Italy, United Kingdom, Greece, Japan, Germany, Sweden
-
Beijing 302 HospitalRecruiting
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
Daiichi Sankyo, Inc.AstraZenecaRecruiting
-
AstraZenecaRecruitingTriple Negative Breast NeoplasmsUnited States, Korea, Republic of, Canada, Taiwan, United Kingdom, Poland
-
MedSIRDaiichi SankyoNot yet recruitingBreast Cancer | Metastatic Breast Cancer
-
Fudan UniversityNot yet recruiting
-
Jonsson Comprehensive Cancer CenterDaiichi Sankyo Co., Ltd.; Translational Research in Oncology-U.SRecruitingInvasive Breast Cancer | Stage II Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Early-stage Breast Cancer | Stage III Breast CancerUnited States
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin HealthCompletedMalignant Solid Tumor | Metastatic EphA2 Positive CancerAustralia
-
Daiichi Sankyo Co., Ltd.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerJapan, United States, Canada
-
Daiichi Sankyo Co., Ltd.CompletedAdvanced Solid Malignant TumorsJapan
-
Institut National de la Santé Et de la Recherche...Ultragenyx Pharmaceutical IncCompletedGlut1 Deficiency SyndromeFrance
-
Daiichi Sankyo, Inc.CompletedHepatic ImpairmentUnited States
-
Daiichi Sankyo Co., Ltd.Completed
-
Daiichi Sankyo Co., Ltd.Completed
-
Daiichi Sankyo Co., Ltd.Terminated
-
Dana-Farber Cancer InstituteGilead Sciences; AstraZeneca; Eisai Inc.; Paxman Coolers Limited; Daiichi SankyoRecruiting
-
Daiichi Sankyo, Inc.RecruitingOvarian Cancer | Metastatic Cancer | Advanced Cancer | Germ Cell TumorUnited States, United Kingdom
-
Daiichi Sankyo Co., Ltd.Daiichi SankyoActive, not recruitingLymphoma, Malignant | Non-hodgkin LymphomaUnited States, Japan
-
Daiichi Sankyo Co., Ltd.Orphan Disease Treatment Institute Co., Ltd.Completed
-
Daiichi Sankyo, Inc.TerminatedLeukemia, Myeloid, Acute | Leukemia, Lymphocytic, AcuteUnited States
-
Zhuan LiaoUnknown
-
Changhai HospitalCompleted
-
Daiichi Sankyo, Inc.CompletedLymphoma | Advanced Solid TumorUnited States
-
Daiichi Sankyo Co., Ltd.Recruiting
-
Hospital St. Joseph, Marseille, FranceRecruitingPancreatitis, ChronicFrance
-
Daiichi Sankyo Co., Ltd.Active, not recruiting
-
M.D. Anderson Cancer CenterDaiichi Sankyo UK Ltd.Terminated
-
Daiichi Sankyo, Inc.Hammersmith Medicines ResearchCompleted
-
Daiichi SankyoRecruiting
-
Chinese University of Hong KongRecruitingBiliary StrictureHong Kong